AMBULATORY INFUSION CENTER MARKET ANALYSIS

Ambulatory Infusion Center Market, By Therapy Type (Blood Product Infusion, Iron Therapy, Steroid Infusion, Immunoglobulin Therapy, Therapeutic Phlebotomy, Plasmapheresis, Clotting Factor Replacement Therapy, and Others), By Application (Diabetic, Cancer, Bone Diseases, Neurodegenerative Diseases, and Others), By End User (Hospitals, Specialty Clinics, Homecare Settings, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In March 2024, Flomed Infusion Services, a company that offers outpatient infusion services, achieved the prestigious NICA Accreditation of Excellence for Ambulatory Infusion Centers, awarded by the National Infusion Center Association (NICA). This accreditation follows a thorough evaluation confirming FloMed's commitment to meeting the highest standards set by NICA.
In February 2024, New Harbor Capital consolidated its investments in Ambulatory Infusion Care North Inc. and JLS Infusion Nurse Staffing Services LLC to establish Access Infusion Care. This unified entity will serve as New Harbor's primary platform for its infusion therapy strategy, targeting the acquisition of top-tier infusion service providers in underserved regions. The strategy focuses on diverse therapy offerings and varied delivery settings, aiming for substantial growth.
In January 2024, Elevance 1Health ,a U.S.-based health insurance company, announced its acquisition of Paragon Healthcare, Inc., a leading provider of critical infusible and injectable therapies. This move is set to bolster Elevance 1Health's presence in the ambulatory infusion centre market.
In August 2023, Uptiv Health, an integrated infusion therapy company, launched a pioneering hybrid infusion care company aimed at transforming the patient experience. The startup inaugurated its inaugural location in Michigan, U.S.